Replies to post #52496 on Biotech Values

[DewDiligence]

Offsetting that, IDEV now gets a 12.5% royalty on sales instead of the old tiered rate of 15-20%.

[rkrw]

Agree its very good news for idev. I think the motivation to the deal is getting a foothold into urology offices in front of a planned intro of botox for refractory oab. Regimen for botox/oab is kind of nasty, a series of injections into the bladder. But they think there's a big market there.